C-reactive protein: clinical and epidemiological perspectives.

作者: Juan Salazar , María Sofía Martínez , Mervin Chávez , Alexandra Toledo , Roberto Añez

DOI: 10.1155/2014/605810

关键词:

摘要: An important etiopathogenic component of cardiovascular disease is atherosclerosis, with inflammation being an essential event in the pathophysiology all clinical pictures it comprises. In recent years, several molecules implicated this process have been studied order to assess risk both primary and secondary prevention. C-reactive protein a plasmatic pentraxin family acute phase reactant, very useful as general marker. Currently, one most profoundly researched field, yet its applicability regarding remains object discussion, considered by some simple marker others true factor. sense, numerous studies propose utilization predictor through use high-sensitivity quantification methods for detection values <1 mg/L, following strict international guidelines. Increasing interest these findings has led creation modified score systems including concentrations, enhance scores commonly used practice offer improved care patients disease, which first cause mortality at worldwide, national, regional scenarios.

参考文章(107)
Yin Ge, Susan Cheng, Martin G. Larson, Anahita Ghorbani, Roderick P. Martin, Rachael J. Klein, Christopher J. O'Donnell, Ramachandran S. Vasan, Stanley Y. Shaw, Thomas J. Wang, Kenneth S. Cohen, Circulating CD31+ leukocyte frequency is associated with cardiovascular risk factors. Atherosclerosis. ,vol. 229, pp. 228- 233 ,(2013) , 10.1016/J.ATHEROSCLEROSIS.2013.04.017
Aroon D Hingorani, Tina Shah, Juan P Casas, Steve E Humphries, Philippa J Talmud, C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target? Clinical Chemistry. ,vol. 55, pp. 239- 255 ,(2009) , 10.1373/CLINCHEM.2008.115923
Gideon M. Hirschfield, Mark B. Pepys, C-reactive protein: a critical update Journal of Clinical Investigation. ,vol. 111, pp. 1805- 1812 ,(2003) , 10.1172/JCI18921
Edward T.H. Yeh, James T. Willerson, Coming of Age of C-Reactive Protein Using Inflammation Markers in Cardiology Circulation. ,vol. 107, pp. 370- 372 ,(2003) , 10.1161/01.CIR.0000053731.05365.5A
Mónica Acevedo, Pilar Arnáiz, Salesa Barja, Claudia Bambs, Ximena Berríos, Beatriz Guzmán, Jacqueline Carvajal, Berta Cassis, Carlos Navarrete, Proteína C reactiva y su relación con adiposidad, factores de riesgo cardiovascular y aterosclerosis subclínica en niños sanos Revista Espanola De Cardiologia. ,vol. 60, pp. 1051- 1058 ,(2007) , 10.1157/13111237
Paul M Ridker, Nader Rifai, Lynda Rose, Julie E Buring, Nancy R Cook, None, Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events The New England Journal of Medicine. ,vol. 347, pp. 1557- 1565 ,(2002) , 10.1056/NEJMOA021993
So Ueda, Uichi Ikeda, Keiji Yamamoto, Masafumi Takahashi, Masanori Nishinaga, Naoki Nago, Kazuyuki Shimada, C-reactive protein as a predictor of cardiac rupture after acute myocardial infarction. American Heart Journal. ,vol. 131, pp. 857- 860 ,(1996) , 10.1016/S0002-8703(96)90164-7
Vivencio Barrios, Ricardo Gómez-Huelgas, Rosario Rodríguez, Pedro de Pablos-Velasco, Adiponectina, un factor de riesgo cardiovascular emergente. Estudio REFERENCE Revista Espanola De Cardiologia. ,vol. 61, pp. 1159- 1167 ,(2008) , 10.1157/13127847
Alissa Collins, Donald Bodenner, Chien Chen, Pamela Stone, Brendan Stack, Delayed treatment of papillary thyroid carcinoma arising from struma ovarii in a patient with history of bilateral salpingo-oophorectomy: a case report. Endocrine Practice. ,vol. 18, ,(2012) , 10.4158/EP11253.CR